Tamara Peterman
Known title: DirectorCIK: 0001774955
Tamara Peterman's purchase track record
How the stock did after each of Tamara Peterman's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
17
of 18 since November 1, 2021
Stock higher 6 months later
53%
3 months: 47%
Median 6-month return
+12.7%
3 months: -1.1%
Beat the S&P 500
59%
median +3.0% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/1/2026 | UMBF | $55K | pending | pending | — |
| 2/2/2026 | UMBF | $20K | +1.4% | +16.7% | +8.9% |
| 11/3/2025 | UMBF | $20K | +19.8% | +21.5% | +5.1% |
| 9/2/2025 | UMBF | $20K | -8.4% | -2.4% | +6.3% |
| 8/1/2025 | UMBF | $20K | -1.1% | +18.1% | +11.2% |
| 3/3/2025 | UMBF | $20K | -5.6% | +12.7% | +9.7% |
| 11/1/2024 | UMBF | $20K | +9.2% | -6.7% | -0.7% |
| 8/1/2024 | UMBF | $39K | +12.7% | +23.9% | +11.5% |
| 2/1/2024 | UMBF | $18K | -1.4% | +18.3% | +11.0% |
| 11/1/2023 | UMBF | $18K | +30.6% | +26.9% | +18.4% |
| 8/1/2023 | UMBF | $18K | -9.2% | +21.6% | +7.6% |
| 6/1/2023 | UMBF | $18K | +8.2% | +23.4% | +8.2% |
| 2/1/2023 | UMBF | $18K | -38.0% | -22.3% | +9.6% |
| 11/1/2022 | UMBF | $18K | +9.5% | -31.6% | +6.8% |
| 8/1/2022 | UMBF | $18K | -7.9% | -2.1% | -2.5% |
| 5/2/2022 | UMBF | $18K | +0.3% | -7.6% | -6.8% |
| 2/1/2022 | UMBF | $15K | -9.7% | -10.1% | -10.0% |
| 11/1/2021 | UMBF | $15K | -2.8% | -10.0% | -9.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| UMBF | ▲ Buy | Open Market | 394 | $55K | 9/1/2026 | View on chart |
| UMBF | ▲ Buy | Grant | 116 | $15K | 5/1/2026 | View on chart |
| UMBF | ▲ Buy | Open Market | 154 | $20K | 2/2/2026 | View on chart |
| UMBF | ▲ Buy | Grant | 786 | $100K | 1/30/2026 | View on chart |
| UMBF | ▲ Buy | Open Market | 185 | $20K | 11/3/2025 | View on chart |
| UMBF | ▲ Buy | Open Market | 163 | $20K | 9/2/2025 | View on chart |
| UMBF | ▲ Buy | Open Market | 183 | $20K | 8/1/2025 | View on chart |
| UMBF | ▲ Buy | Open Market | 179 | $20K | 3/3/2025 | View on chart |
| UMBF | ▲ Buy | Grant | 678 | $80K | 1/31/2025 | View on chart |
| UMBF | ▲ Buy | Open Market | 181 | $20K | 11/1/2024 | View on chart |
| UMBF | ▲ Buy | Open Market | 396 | $39K | 8/1/2024 | View on chart |
| UMBF | ▲ Buy | Grant | 790 | $65K | 2/2/2024 | View on chart |
| UMBF | ▲ Buy | Open Market | 216 | $18K | 2/1/2024 | View on chart |
| UMBF | ▲ Buy | Open Market | 281 | $18K | 11/1/2023 | View on chart |
| UMBF | ▲ Buy | Open Market | 253 | $18K | 8/1/2023 | View on chart |
| UMBF | ▲ Buy | Open Market | 307 | $18K | 6/1/2023 | View on chart |
| UMBF | ▲ Buy | Open Market | 195 | $18K | 2/1/2023 | View on chart |
| UMBF | ▲ Buy | Grant | 739 | $65K | 1/27/2023 | View on chart |
| UMBF | ▲ Buy | Open Market | 213 | $18K | 11/1/2022 | View on chart |
| UMBF | ▲ Buy | Open Market | 196 | $18K | 8/1/2022 | View on chart |
| UMBF | ▲ Buy | Open Market | 195 | $18K | 5/2/2022 | View on chart |
| UMBF | ▲ Buy | Open Market | 148 | $15K | 2/1/2022 | View on chart |
| UMBF | ▲ Buy | Grant | 610 | $60K | 1/28/2022 | View on chart |
| UMBF | ▲ Buy | Open Market | 146 | $15K | 11/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
UMB Financial sees price target cuts from JP Morgan, Wells Fargo, Morgan Stanley
Three major banks recently lowered their price targets for UMB Financial, with JP Morgan and Wells Fargo cutting theirs to $160 and $147 respectively. Morgan Stanley also reduced its target to $182 while maintaining an Overweight rating. These adjustments provide a new baseline for the stock's valuation, which currently trades near its 52-week low.
UMB Financial sees price target cuts from JP Morgan, Wells Fargo, Morgan Stanley. Three major banks recently lowered their price targets for UMB Financial, with JP Morgan and Wells Fargo cutting theirs to $160 and $147 respectively. Morgan Stanley also reduced its target to $182 while maintaining an Overweight rating. These adjustments provide a new baseline for the stock's valuation, which currently trades near its 52-week low.